A new interactive training tool designed to help oncologists better address patient fears has been developed by a Duke University researcher. The program includes feedback on the doctors’ audio-recorded visits with patients and offers an alternative to higher-priced courses. The study appears in the Annals of Internal Medicine.
The research team found that the curriculum resulted in more empathic responses from oncologists. Furthermore, patients reported greater trust in their doctors, an important factor of care that enhances quality of life.
Research published in the latest issue of the Journal of the American Medical Association found that as few as 3 to 6 glasses of wine per week increased a woman’s chance of developing breast cancer. The risk of breast cancer also rose based on the amount of alcohol consumed cumulatively throughout her lifetime.
A unique library representing an important new tool for accelerating the development of an entire class of targeted cancer drugs has been created by scientists at Fox Chase Cancer Center. The actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical for cancer, have been cataloged and cross-indexed. Read More ›
Chemotherapy combined with an experimental vaccine, TG4010, resulted in more progression-free survival in patients with advanced lung cancer, according to a recent study published in The Lancet Oncology.
The TG4010 vaccine targets MUC1, a protein associated with non–small cell lung cancer (NSCLC), the most common form of lung cancer.
The phase 2 trial, led by Elisabeth Quoix, MD, a professor of pneumonology at the Université de Strasbourg, included 148 patients with NSCLC.
Patients were divided into 2 groups:
Postmenopausal women enrolled in the Women’s Health Initiative (WHI) who took nonsteroidal anti-inflammatory drugs (ie, aspirin or ibuprofen) appeared to have a lower risk of death from colorectal cancer than women who did not use these medications, according to new study results.
The results of 3 studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be used as a staging and possible therapeutic tool for patients with prostate cancer.
One study found that C-11 choline PET/CT scans, although not necessarily better, can be utilized as a staging tool instead of multiple x-rays.
Radiotherapy following surgery for breast cancer reduces the chances of cancer recurrence by 50% over the next 10 years, andit minimizes the risk of breast cancer mortality by one-sixth for the 15 years following surgery, a study led by Oxford University researchers has found.
Older women diagnosed with hormone-sensitive breast cancer are more likely to live longer and less likely to experience cancer recurrence when treated with the drug Femara (letrozole) as opposed to tamoxifen, a long-term follow-up study published online October 21 in The Lancet Oncology shows.
Although many patients with cancer have benefited from new drug discoveries over the last decade, a common side effect of these newly developed therapies may be inadvertent effects on the thyroid gland, according to a report published online in the Journal of the National Cancer Institute.
To sign up for our newsletter or print publications, please enter your contact information below.
